Target intelligence / Profile preview

Growth factor and cytokine receptors on human umbilical cord mesenchymal stem cells

Molecular classification
Receptor, Growth factor receptor, Cytokine receptor, Tyrosine kinase receptor, G protein-coupled receptor
01

Overview

Growth factor and cytokine receptors on human umbilical cord mesenchymal stem cells (hUC-MSCs) represent a broad class of cell-surface proteins essential for the biological activity and therapeutic potential of these multipotent cells. These receptors, including those for TGF-beta, VEGF, and various interleukins, enable hUC-MSCs to sense and respond to the physiological environment, particularly in inflammatory or damaged tissue niches (Source: PMC6396355). Activation of these receptors governs critical processes such as self-renewal, multi-lineage differentiation, and the secretion of immunomodulatory factors (Source: PubMed 31035405). In clinical applications, these receptors are vital for the therapeutic 'homing' mechanism, where MSCs migrate toward injury signals to promote tissue regeneration and suppress excessive immune responses (Source: NIH/NCBI). While this term describes a collective group of proteins rather than a single molecular target, understanding their expression profile is crucial for optimizing MSC-based therapies for conditions like graft-versus-host disease and autoimmune disorders.

Other names
hUC-MSC surface receptorsMesenchymal stem cell cytokine receptorsUmbilical cord MSC growth factor receptorshUC-MSC signaling receptors
02

Mechanism of action

Activation of intracellular signaling pathways such as JAK/STAT, PI3K/Akt, and MAPK upon ligand binding to modulate cellular behavior, survival, and the secretion of immunomodulatory paracrine factors.

03

Biological functions

Signal transductionCell proliferationCell differentiationImmunomodulationTissue repairCell migrationParacrine signaling
04

Disease associations

InflammationAutoimmune diseaseGraft-versus-host diseaseCardiovascular diseaseNeurological disordersWound healing
05

Safety considerations

Potential for unwanted or ectopic differentiationRisk of promoting tumor growth through paracrine signalingVariable receptor expression due to donor heterogeneityEfficiency of homing to target tissues
06

Interacting drugs

Transforming growth factor beta

5 more in the full profile.

07

Biomarkers

CD73CD90CD105CXCR4PDGFRVEGFR

Beyond the preview

Go deeper on Growth factor and cytokine receptors on human umbilical cord mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth factor and cytokine receptors on human umbilical cord mesenchymal stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call